Håvard Hildeng Hauge
Chief Executive Officer at Biomolex AS
Profile
Håvard Hildeng Hauge is currently the Chief Executive Officer at Biomolex AS since 2001.
He was previously the Chief Executive Officer at PubGene AS and Manager-Business Development at Spermatech AS.
Hauge holds a doctorate degree from the University of Oslo, which he received in 1999.
Håvard Hildeng Hauge active positions
| Companies | Position | Start |
|---|---|---|
Biomolex AS
 Biomolex AS Medical SpecialtiesHealth Technology Biomolex AS develops and delivers imaging systems for digital autoradiography. It offers Biomolex 700, a digital imager for protein micro-array analysis, including kinase analyses, protein interaction assays, single istotope deoxyribonucleic acid array analyses, micro analyses; and tissue imaging applications, such as foreign genetic material delivery, tissue specific distributions, uptake of antibodies, and uptake of labeled bio-molecules. The company was founded in May 2001 and is headquartered in Oslo, Norway. | Chief Executive Officer | 31/12/2000 |
Former positions of Håvard Hildeng Hauge
| Companies | Position | End |
|---|---|---|
PubGene AS
 PubGene AS Medical SpecialtiesHealth Technology PubGene AS manufactures medical devices. The private company is based in Oslo, Norway. | Chief Executive Officer | - |
Spermatech AS
 Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway. | Corporate Officer/Principal | - |
Training of Håvard Hildeng Hauge
| University of Oslo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Biomolex AS
Biomolex AS Medical SpecialtiesHealth Technology Biomolex AS develops and delivers imaging systems for digital autoradiography. It offers Biomolex 700, a digital imager for protein micro-array analysis, including kinase analyses, protein interaction assays, single istotope deoxyribonucleic acid array analyses, micro analyses; and tissue imaging applications, such as foreign genetic material delivery, tissue specific distributions, uptake of antibodies, and uptake of labeled bio-molecules. The company was founded in May 2001 and is headquartered in Oslo, Norway. | Health Technology |
Spermatech AS
Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway. | Health Technology |
PubGene AS
PubGene AS Medical SpecialtiesHealth Technology PubGene AS manufactures medical devices. The private company is based in Oslo, Norway. | Health Technology |
- Stock Market
- Insiders
- Håvard Hildeng Hauge